Seeking Alpha

Par Pharmaceutical (PRX -2.7%) trades lower after saying late Friday that it's challenging a...

Par Pharmaceutical (PRX -2.7%) trades lower after saying late Friday that it's challenging a federal rule that it claims infringes on its first-amendment right to promote its anorexia treatment Megace ES. Doctors feel the drug could benefit a variety of patients outside the FDA approved AIDS-only spectrum, but the company says the FDA is blocking it from discussing treatment options.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs